Variant · Snv
KRAS NM_004985.5(KRAS):c.40G>A (p.Val14Ile)
CI-VAR-00006077Explore in graph →p.Val14IleNM_004985.5:c.40G>AClinVar 12589 rs104894365
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 12589 | Pathogenic | reviewed by expert panel | 3 | Noonan syndrome 3; Endometrial carcinoma; RASopathy; Cardio-facio-cutaneous syndrome; Noonan syndrome; Noonan syndrome and Noonan-related syndrome; Cardiofaciocutaneous syndrome 2; Cardiovascular phenotype; Colorectal cancer; KRAS-related disorder | germline/somatic | 26 | Dec 03, 2024 | clinvar |